Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01427179 · ClinicalTrials.gov registry record
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 2,000
- Enrollment target
NCT01427179: Recruiting study, sponsored by Mayo Clinic.
NCT01427179 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01427179 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person.
Primary Outcome
Via GWAS and whole exome sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2011-05 |
| Est. Completion | 2030-12 |
What NCT01427179 shows while recruiting
NCT01427179 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01427179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01427179 about?
NCT01427179 is a clinical study titled "Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)". The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent b...
What is the current status of trial NCT01427179?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2011-05. Estimated completion is 2030-12.
Who is sponsoring clinical trial NCT01427179?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia